CDMO industry experts explain evolving demand, regulatory shifts, and analytical challenges shaping the HPAPI contract manufacturing market. Read More >>
149 marketing leaders shared their predictions and strategies in the 2026 CDMO Marketing Trends Report. Join Contract Pharma and Altitude Marketing on January 29th to explore the results and share their insight.
PLD Pharma Services is a full-service CDMO providing end-to-end development and manufacturing for oral and solid dose Rx and OTC drugs across multiple delivery systems. With comprehensive R&D and analytical labs, an extensive formulation library, and a portfolio of more than 60 ANDAs, PLD supports products in solids, liquids, lozenges, and gummies. Backed by three decades of expertise, our integrated team advances programs from early concept through scale-up and commercial launch—all within a single, integrated team.
Siegfried offers contract development and manufacturing of APIs, intermediates, and finished dosage forms. From early-phase development to commercial scale, its integrated approach ensures comprehensive services, including process development, registration, production, packaging, and logistics. Siegfried operates 13 facilities in 7 countries worldwide.
